131 related articles for article (PubMed ID: 12378063)
1. Experimental parkinsonism in primates.
Matsumura M
Stereotact Funct Neurosurg; 2001; 77(1-4):91-7. PubMed ID: 12378063
[TBL] [Abstract][Full Text] [Related]
2. The role of the pedunculopontine tegmental nucleus in experimental parkinsonism in primates.
Matsumura M; Kojima J
Stereotact Funct Neurosurg; 2001; 77(1-4):108-15. PubMed ID: 12378066
[TBL] [Abstract][Full Text] [Related]
3. The dopaminergic nigropallidal projection in primates: distinct cellular origin and relative sparing in MPTP-treated monkeys.
Parent A; Lavoie B; Smith Y; Bédard P
Adv Neurol; 1990; 53():111-6. PubMed ID: 1978512
[TBL] [Abstract][Full Text] [Related]
4. Subthalamo-pallidal interactions underlying parkinsonian neuronal oscillations in the primate basal ganglia.
Tachibana Y; Iwamuro H; Kita H; Takada M; Nambu A
Eur J Neurosci; 2011 Nov; 34(9):1470-84. PubMed ID: 22034978
[TBL] [Abstract][Full Text] [Related]
5. Lesions in monkey globus pallidus externus exacerbate parkinsonian symptoms.
Zhang J; Russo GS; Mewes K; Rye DB; Vitek JL
Exp Neurol; 2006 Jun; 199(2):446-53. PubMed ID: 16487515
[TBL] [Abstract][Full Text] [Related]
6. Regulation of dopamine receptor and neuropeptide expression in the basal ganglia of monkeys treated with MPTP.
Betarbet R; Greenamyre JT
Exp Neurol; 2004 Oct; 189(2):393-403. PubMed ID: 15380489
[TBL] [Abstract][Full Text] [Related]
7. Neural mechanisms underlying parkinsonian symptoms based upon regional uptake of 2-deoxyglucose in monkeys exposed to 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine.
Mitchell IJ; Clarke CE; Boyce S; Robertson RG; Peggs D; Sambrook MA; Crossman AR
Neuroscience; 1989; 32(1):213-26. PubMed ID: 2586750
[TBL] [Abstract][Full Text] [Related]
8. [Parkinsonism induced by MPTP as an experimental model of Parkinson disease: similarities and differences].
Luquin MR; Obeso JA; Herrero MT; Laguna J; Martínez-Lage JM
Neurologia; 1991 Oct; 6(8):287-94. PubMed ID: 1790005
[TBL] [Abstract][Full Text] [Related]
9. Monoamine oxidase-inhibition and MPTP-induced neurotoxicity in the non-human primate: comparison of rasagiline (TVP 1012) with selegiline.
Kupsch A; Sautter J; Götz ME; Breithaupt W; Schwarz J; Youdim MB; Riederer P; Gerlach M; Oertel WH
J Neural Transm (Vienna); 2001; 108(8-9):985-1009. PubMed ID: 11716151
[TBL] [Abstract][Full Text] [Related]
10. The neurophysiology and effect of deep brain stimulation in a patient with 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-induced parkinsonism.
Christine CW; Langston JW; Turner RS; Starr PA
J Neurosurg; 2009 Feb; 110(2):234-8. PubMed ID: 19099380
[TBL] [Abstract][Full Text] [Related]
11. Reversal of akinesia in experimental parkinsonism by GABA antagonist microinjections in the pedunculopontine nucleus.
Nandi D; Aziz TZ; Giladi N; Winter J; Stein JF
Brain; 2002 Nov; 125(Pt 11):2418-30. PubMed ID: 12390969
[TBL] [Abstract][Full Text] [Related]
12. Tremor-related activity of neurons in the 'motor' thalamus: changes in firing rate and pattern in the MPTP vervet model of parkinsonism.
Guehl D; Pessiglione M; François C; Yelnik J; Hirsch EC; Féger J; Tremblay L
Eur J Neurosci; 2003 Jun; 17(11):2388-400. PubMed ID: 12814370
[TBL] [Abstract][Full Text] [Related]
13. Chapter 33: the history of movement disorders.
Lanska DJ
Handb Clin Neurol; 2010; 95():501-46. PubMed ID: 19892136
[TBL] [Abstract][Full Text] [Related]
14. Evidence for a dopaminergic innervation of the pedunculopontine nucleus in monkeys, and its drastic reduction after MPTP intoxication.
Rolland AS; Tandé D; Herrero MT; Luquin MR; Vazquez-Claverie M; Karachi C; Hirsch EC; François C
J Neurochem; 2009 Aug; 110(4):1321-9. PubMed ID: 19527435
[TBL] [Abstract][Full Text] [Related]
15. Thalamic neuronal activity in dopamine-depleted primates: evidence for a loss of functional segregation within basal ganglia circuits.
Pessiglione M; Guehl D; Rolland AS; François C; Hirsch EC; Féger J; Tremblay L
J Neurosci; 2005 Feb; 25(6):1523-31. PubMed ID: 15703406
[TBL] [Abstract][Full Text] [Related]
16. Neuronal firing before and after burst discharges in the monkey basal ganglia is predictably patterned in the normal state and altered in parkinsonism.
Wichmann T; Soares J
J Neurophysiol; 2006 Apr; 95(4):2120-33. PubMed ID: 16371459
[TBL] [Abstract][Full Text] [Related]
17. Protection against dopaminergic nigrostriatal cell death by excitatory input ablation.
Takada M; Matsumura M; Kojima J; Yamaji Y; Inase M; Tokuno H; Nambu A; Imai H
Eur J Neurosci; 2000 May; 12(5):1771-80. PubMed ID: 10792454
[TBL] [Abstract][Full Text] [Related]
18. Dopamine replacement therapy reverses abnormal synchronization of pallidal neurons in the 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine primate model of parkinsonism.
Heimer G; Bar-Gad I; Goldberg JA; Bergman H
J Neurosci; 2002 Sep; 22(18):7850-5. PubMed ID: 12223537
[TBL] [Abstract][Full Text] [Related]
19. Low-pass filter properties of basal ganglia cortical muscle loops in the normal and MPTP primate model of parkinsonism.
Rivlin-Etzion M; Marmor O; Saban G; Rosin B; Haber SN; Vaadia E; Prut Y; Bergman H
J Neurosci; 2008 Jan; 28(3):633-49. PubMed ID: 18199764
[TBL] [Abstract][Full Text] [Related]
20. A 2-deoxyglucose study of the effects of dopamine agonists on the parkinsonian primate brain. Implications for the neural mechanisms that mediate dopamine agonist-induced dyskinesia.
Mitchell IJ; Boyce S; Sambrook MA; Crossman AR
Brain; 1992 Jun; 115 ( Pt 3)():809-24. PubMed ID: 1628204
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
